kenpaullone

Also, the kinase inhibitor kenpaullone was found to replace Klf4 [63], although the underlying mechanism is unknown at present.

BioMed Central - Latest articles Cesar Sommer 2010

The screening process identified two tiny molecules, kenpaullone and roscovitine, which only weakly bind to hPXR but strongly activate its signaling pathway.

unknown title 2009

The screening process identified two tiny molecules, kenpaullone and roscovitine, which only weakly bind to hPXR but strongly activate its signaling pathway.

unknown title 2009

Chen's team found that in addition to this weak binding to hPXR, kenpaullone and roscovitine can inhibit a group of enzymes known as cyclin-dependent kinases (Cdks).

unknown title 2009

Chen's team found that in addition to this weak binding to hPXR, kenpaullone and roscovitine can inhibit a group of enzymes known as cyclin-dependent kinases (Cdks).

unknown title 2009

Chen's team found that in addition to this weak binding to hPXR, kenpaullone and roscovitine can inhibit a group of enzymes known as cyclin-dependent kinases (Cdks).

unknown title 2009

Chen's team found that in addition to this weak binding to hPXR, kenpaullone and roscovitine can inhibit a group of enzymes known as cyclin-dependent kinases (Cdks).

unknown title 2009

The screening process identified two tiny molecules, kenpaullone and roscovitine, which only weakly bind to hPXR but strongly activate its signaling pathway.

unknown title 2009

The screening process identified two tiny molecules, kenpaullone and roscovitine, which only weakly bind to hPXR but strongly activate its signaling pathway.

unknown title 2009

The screening process identified two tiny molecules, kenpaullone and roscovitine, which only weakly bind to hPXR but strongly activate its signaling pathway.

unknown title 2009